Free toolNo sign-up

CDMO FDA inspection lookup

Type a contract manufacturer, a site or an FEI number. See every FDA inspection outcome, warning letter and recall on file for it, by site, in seconds, with the industry's NAI, VAI and OAI split to compare against.

Try: , , ,

Medline Industries, LP

Northfield, IL · Devices · Drugs · Medical Devices

FDA has published 1 inspection, 1 warning letter and 71 recalls naming Medline Industries, LP.

1InspectionLatest 2026-07-22: Official action indicated
1Warning letterLatest 2026-04-07
71RecallsLatest 2026-10-14: Class II

Site: Mundelein, IL (1, latest OAI)

0% of Medline Industries, LP's inspection closed with no action (NAI), against 44% of the 452 drug inspections FDA has posted with end dates since March 30, 2026 (44% NAI, 46% VAI, 10% OAI).

  • 2026-10-14Class II recallRollator, Bariatric, Basic Steel, Blue, mechanical walker with four legs and a metal frame intended for medical purposes to provide moderate… · DevicesClass IIRecall
  • 2026-10-14Class II recallRollator, Bariatric, Basic Steel, Burgundy, mechanical walker with four legs and a metal frame intended for medical purposes to provide mode… · DevicesClass IIRecall
  • 2026-10-07Class I recallMedline Basic Homecare Beds and Medlite Homecare Beds and Accessories, Hand Pendants: MDR510094 PENDANT F/ MDR107002E MDR520094 PENDANT F/ M… · DevicesClass IRecall
  • 2026-10-07Class I recallMedline Basic Homecare Beds and Medlite Homecare Beds and Accessories MDR107000P BED, MANUAL, MEDLITE · DevicesClass IRecall
  • 2026-09-30Class II recallMedline convenience kits containing Healthmark Instrument Channel Brushes. SINUS PACK DYNJ48258D and Sinus Pack DYNJ48258F. · DevicesClass IIRecall
  • 2026-09-30Class II recallMedline Convenience Kits: 1) MAJOR PACK, Catalog Number: DYNJ81325A · DevicesClass IIRecall
  • 2026-09-30Class II recallMedline Convenience Kits: 1) MAJOR NEURO VCH, Catalog Number: DYNJ39218I; 2) NEURO PACK-LF, Catalog Number: DYNJ41246F; 3) CRANIOTOMY PACK (… · DevicesClass IIRecall
  • 2026-09-30Class II recallMedline Convenience Kits: 1) PEDS SINUS PACK, Catalog Number: DYNJ02516G; 2) SINUS PACK-LF, Catalog Number: DYNJ0342705J; 3) NASAL-LF, Catal… · DevicesClass IIRecall

65 more records: see the company page.

Know the day FDA posts the next one on Medline Industries, LP

Name the CDMOs you compete with, the sites you run and the biotechs you sell to. One email when FDA inspects, writes to or recalls from any of them, with the record linked. A free account shows every source for the last 7 days. No card.

Start free

What you get

  • Every inspection outcome, by site. NAI, VAI or OAI, the product type and the site, from FDA's Data Dashboard, for 1,505 inspection outcomes with end dates from March 30, 2026 to October 8, 2026. A name finds every site FDA lists under it; an FEI number finds one site and the company behind it.
  • Warning letters and recalls. Each letter with its subject and issuing office; each recall with its class and product, from FDA's own listings, posted since May 20, 2025.
  • The benchmark. The company's share of no-action inspections against the share across all 1,505 inspections held (64% NAI, 33% VAI, 3% OAI), or against the inspections under the same product type when the company has one.
  • The record itself. Every row links to a page that states what FDA published and links to the agency's record.

Why CDMOs check this

Sponsors are checking you. A biotech's quality team looks up a manufacturer's FDA record before an audit, a quote and a tech transfer. This is the page they see, in the words FDA used.

Competitors change on inspection day. An OAI or a warning letter at another site is the week a sponsor starts looking for a second source. The record is public the day FDA posts it.

Your own sites, in one place. One name finds every site FDA lists under it, with the outcome of each visit, instead of one dashboard query per FEI.

What the outcomes mean

NAI
No action indicated. No objectionable conditions were found, or none that justify further action.
VAI
Voluntary action indicated. Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
OAI
Official action indicated. Regulatory or administrative action is recommended. A warning letter, an import alert or a consent decree can follow.

FDA posts a classification after its review of the inspection is complete, often months after the inspection ended. Browse all inspection classifications, warning letters and recalls held, or look a company up in the company directory.

Questions

Inspection classifications are from the FDA Data Dashboard; warning letters from FDA's listing; recalls from FDA's enforcement reports through openFDA. A record may have changed since it was read. The benchmark is a count of the records held, not a rating.

Approve Suite is not affiliated with FDA or with any company shown. Informational only, not regulatory, legal or medical advice. See pricing and the FAQ for what the full product does.